HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

MicroPort MedBot (2252.HK)- Lack an “anchor” for Valuation Due to Uncertainties in Commercialization

Topsports International (6110.HK) - Has the Potential to Turn Things Around Despite the Headwinds

Topsports International: CCP's ZERO COVID Policy Has a Bigger Whopper Impact than Cheap Valuations

The Impact of HFCAA on China ADR (China Healthcare Companies)

Shanghai MicroPort MedBot Group (2252.HK) - Optimistic About the Outlook

China Healthcare Weekly (Mar18)-Leaked Document On Medical Service,Biotech Valuation,CE Mark Upgrade

Gravity Works As WeWork Doesn't; Now Plan B

Thematic (Sector/Industry)

Hong kong Healthcare equipment and services / Thematic (Sector/Industry)

<ul>
<li>Laparoscopic surgical robots are one of the most important R&amp;D directions of surgical robots, which is the largest market segment and can be applied in a broad range of surgeries.</li>
<li>The launch of laparoscopic surgical robot from domestic companies with high cost performance would be very helpful to seize the markets with great potential in early stage of the industry.</li>
<li>The medical insurance coverage offers a viable way for the commercialization of surgical robots in China, which is important. The revenue/profits generated from disposables and services would be more attractive.</li>
</ul>


Laparoscopic surgical robots are one of the most important R&amp;D directions of surgical robots, which is the largest market segment and can be applied in a broad range of surgeries.
The launch of laparoscopic surgical robot from domestic companies with high cost performance would be very helpful to seize the markets with great potential in early stage of the industry.
The medical insurance coverage offers a viable way for the commercialization of surgical robots in China, which is important. The revenue/profits generated from disposables and services would be more attractive.


Shanghai MicroPort MedBot Group (2252 HK)

Industry Report – Insights on China Surgical Robots Industry